美康生物品牌怎么样 申请店铺

我要投票 美康生物在医疗器械行业中的票数:408 更新时间:2025-07-02
美康生物是哪个国家的品牌?「美康生物」是美康盛德旗舰店旗下著名品牌。该品牌发源于浙江省宁波市,由创始人邹 * 德在2003年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力美康生物品牌出海!将品牌入驻外推网,定制美康生物品牌推广信息,可以显著提高美康生物产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

美康生物怎么样

美康生物是一家专业从事医学诊断产品研发、生产、销售及服务的企业。公司创立于2003年,矗立于宁波,2015年在深交所创业板成功上市,股票代码300439。

美康生物主要产业为体外诊断试剂、仪器及独立第三方医学诊断服务。公司秉承以人为本、科技创新的宗旨来建立自己的特色,严格按照GMP标准组织生产。目前已取得140余项体外诊断试剂产品注册证书,是我国生化诊断试剂领域品种齐全的供应商之一;并取得9项诊断仪器产品注册证书,是行业内同时能够提供诊断试剂和诊断仪器的少数供应商之一。

公司打造以提供区域性医学检验服务为核心的第三方医学检验中心。拥有自主研发的区域LIS系统、现代化消毒中心、冷链物流系统、美康云平台等多项配套系统。大力助推分级诊疗的落地,加快各级医疗机构信息化改革的步伐,提升医院的管理水平、服务质量及综合竞争力。

美康生物成为医学检验集约化系统供应商,为客户提供实验室整体解决方案。公司将持续推出高科技含量产品,深入提供服务,为客户创造价值,为中国体外诊断事业的发展,为中国人民的健康做出更大贡献!


Meikang biology is a professional enterprise engaged in the research and development, production, sales and service of medical diagnosis products. Founded in 2003 and standing in Ningbo, the company was successfully listed on the growth enterprise market of Shenzhen Stock Exchange in 2015, with the stock code of 300439. Our main industries are in vitro diagnostic reagents, instruments and independent third-party medical diagnostic services. The company adheres to the tenet of people-oriented and scientific and technological innovation to establish its own characteristics and organize production in strict accordance with GMP standards. At present, it has obtained more than 140 in vitro diagnostic reagent product registration certificates, and is one of the suppliers with complete varieties in the field of biochemical diagnostic reagents in China. It has also obtained 9 registration certificates of diagnostic instrument products, which is one of the few suppliers in the industry that can provide diagnostic reagents and diagnostic instruments at the same time. The company has built a third-party medical testing center with the core of providing regional medical testing services. It has self-developed regional LIS system, modern disinfection center, cold chain logistics system, Meikang cloud platform and other supporting systems. Vigorously promote the implementation of hierarchical diagnosis and treatment, accelerate the pace of information-based reform of medical institutions at all levels, and improve the management level, service quality and comprehensive competitiveness of hospitals. Meikang biology has become a supplier of intensive medical testing system, providing customers with overall laboratory solutions. The company will continue to launch high-tech products, provide in-depth services, create value for customers, and make greater contributions to the development of China's in vitro diagnostic industry and the health of the Chinese people!

本文链接: https://brand.waitui.com/eed8e50ac.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

上半年浦东机场入出境外籍人员破500万人次 同比增46%

从上海边检获悉,截至2025年6月30日,上海机场边检站在浦东国际机场口岸累计查验入出境外籍人员突破500万人次,较2024年同期增长46%。(澎湃)

2小时前

美股大型科技股美股盘前多数下跌,特斯拉跌近6%

36氪获悉,美股大型科技股美股盘前多数下跌,截至发稿,特斯拉跌近6%,英伟达跌超1%,Meta跌0.34%,亚马逊跌0.29%,谷歌跌0.19%,奈飞跌0.17%;苹果涨0.88%,微软涨0.08%。

2小时前

热门中概股美股盘前多数走弱,京东跌0.77%

36氪获悉,热门中概股美股盘前多数走弱,截至发稿,京东跌0.77%,阿里巴巴跌0.63%,拼多多跌0.42%,理想汽车跌0.41%,哔哩哔哩跌0.37%,百度跌0.35%,理想汽车跌0.22%;小鹏汽车涨0.67%,蔚来涨0.3%。

2小时前

动力新科:全资子公司上汽红岩被申请重整

36氪获悉,动力新科公告,公司全资子公司上汽红岩的债权人重庆安吉物流向重庆五中院申请上汽红岩破产重整。上汽红岩尚未收到债权人的有关告知函,重庆五中院已立案(案号:(2025)渝05破申436号)。上汽红岩为公司重要子公司及重卡业务生产经营平台,若重整成功实施,将有利于化解债务、缓解公司经营压力。但上汽红岩是否被裁定进入重整程序尚存在不确定性,即使进入重整程序,也不代表重整成功。公司将及时披露有关事项的进展情况。

2小时前

美国财长贝森特预计参议院将于今天下午通过税改法案

美国财政部长斯科特·贝森特预计参议院将于今日下午通过总统特朗普的税收和支出法案。(新浪财经)

2小时前

本页详细列出关于美康生物的品牌信息,含品牌所属公司介绍,美康生物所处行业的品牌地位及优势。
咨询